Revenue -- $2.96 billion in Q4, up over 13% organically FX-neutral, with a 160-basis-point foreign exchange tailwind to spot growth. Shareholder returns -- $756 million returned in Q4 via $625 million ...
Hinge Health (HNGE) analysis: 2025 growth, strong FCF margins, and a durable AI-resistant moat. Click here to read my most recent analysis of HNGE stock.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果